Reuters logo
BRIEF-Acerus files a new drug submission for Gynoflor(TM) in Canada
March 1, 2017 / 12:49 PM / 7 months ago

BRIEF-Acerus files a new drug submission for Gynoflor(TM) in Canada

March 1 (Reuters) - Acerus Pharmaceuticals Corporation

* Acerus files a new drug submission for Gynoflor(TM) in Canada

* Acerus Pharmaceuticals - NDA for gynoflor for treatment of symptoms of vaginal atrophy, for restoration of vaginal flora following use of anti-infectives Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below